Author:
Pan Zenggang,Chen Mingyi,Zhang Qianyun,Wang Endi,Yin Liqun,Xu Youyuan,Huang Qin,Yuan Youzhong,Zhang Xiaohui,Zheng Gang,Yuan Ji
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference30 articles.
1. Thakral B, Medeiros LJ, Desai P et al. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 2016;98:415–421.
2. Kaleem Z, White G, Zutter MM . Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas. Am J Clin Pathol 2001;115:396–403.
3. Suzuki Y, Yoshida T, Wang G et al. Incidence and clinical significance of aberrant T-cell marker expression on diffuse large B-cell lymphoma cells. Acta Haematol 2013;130:230–237.
4. Pan Z, Hu S, Li M et al. ALK-positive large B-cell lymphoma: a clinicopathologic study of 26 cases with review of additional 108 cases in the literature. Am J Surg Pathol 2017;41:25–38.
5. Matnani RG, Stewart RL, Pulliam J et al. Peripheral T-cell lymphoma with aberrant expression of CD19, CD20, and CD79a: case report and literature review. Case Rep Hematol 2013;2013:183134.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献